MRIガイド下脳神経外科アブレーション市場：製品別、エンドユーザー別-2025-2030年の世界予測

MRIガイド下脳神経外科アブレーション市場は、2023年に38億9,000万米ドルと評価され、2024年には40億7,000万米ドルに達すると予測され、CAGR 4.84%で成長し、2030年には54億2,000万米ドルに達すると予測されています。

MRIガイド下脳神経外科アブレーションの対象範囲には、脳組織の切除や除去を目的とした低侵襲外科手術のガイドとしてMRI技術を使用することが含まれます。この技術は、病態の正確なターゲティングを可能にし、周囲の健康な組織への潜在的な損傷を低減することで、患者の転帰と回復時間を向上させるため、不可欠であることが証明されています。その用途は幅広く、てんかん、脳腫瘍、パーキンソン病などの神経疾患に及び、最終用途は主に病院、専門クリニック、研究機関です。主な成長要因としては、神経疾患の有病率の増加、低侵襲手術に対する需要の高まり、精度と安全性を向上させるMRI技術の進歩などが挙げられます。ヘルスケアのインフラが整備され、高齢化人口が拡大するにつれて、市場成長の機会も同様に拡大します。画像判読の強化と個別化治療計画のための人工知能の統合は、技術革新の可能性を示す分野です。

しかし、高い機器コストや複雑な技術を操作できる熟練した専門家の需要など、いくつかの限界や課題が市場の成長を阻害する可能性があります。さらに、規制や償還に関する課題は、特に医療制度が整備されていない新興国市場での迅速な市場浸透を妨げる可能性があります。市場競争は激しく、有力企業は研究開発に多額の投資を行っているため、競争力を維持するためには継続的な技術革新が必要です。新たな市場機会を捉えるための提言としては、AI主導のプラットフォーム開発への投資、技術アクセスを拡大するためのパートナーシップ、新たな治療用途を検証するための臨床試験プログラムの拡大などが挙げられます。MRIガイド下手技の利点について、医療界と患者の双方を教育することに重点を置くことで、採用率を高めることができます。技術革新の中心は、MRIガイド下焼灼術の手技効率、費用対効果、治療成績の改善です。持続的な成長には、規制上の障害を克服し、償還の問題に対処する先進的なアプローチも不可欠です。このような力学を踏まえると、市場は今後も急速な進化を続けると予想され、技術的進歩や、より多くの地域での採用拡大が特徴です。

市場力学：急速に進化するMRIガイド下脳神経外科アブレーション市場の主要市場インサイトを公開

MRIガイド下脳神経外科アブレーション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で急速に増加する老年人口に伴う脳腫瘍の有病率の増加
  • 低侵襲脳外科手術の採用急増
  • 脳疾患の診断と治療に対する患者の意識の高まり
• 市場抑制要因
  • MRIガイド下脳神経外科アブレーションに関連する高コスト
• 市場機会
  • 新興国におけるヘルスケア支出の急増
  • 神経外科的アブレーションに関する技術進歩および研究活動の増加
• 市場の課題
  • 熟練した人材の不足

ポーターの5つの力：MRIガイド下脳神経外科アブレーション市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：MRIガイド下脳神経外科アブレーション市場における外部からの影響の把握

外部マクロ環境要因は、MRIガイド下脳神経外科アブレーション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析MRIガイド下脳神経外科アブレーション市場における競合情勢の把握

MRIガイド下脳神経外科アブレーション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスMRIガイド下脳神経外科アブレーション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、MRIガイド下脳神経外科アブレーション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨MRIガイド下脳神経外科アブレーション市場における成功への道筋を描く

MRIガイド下脳神経外科アブレーション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢化が急速に進む中、脳腫瘍の罹患率も増加している
    • 低侵襲脳神経外科手術の導入急増
    • 患者における脳疾患の診断と治療意識の高まり
  • 抑制要因
    • MRIガイド下脳神経外科アブレーションに関連する高コスト
  • 機会
    • 新興国におけるヘルスケア費の急増
    • 脳神経外科アブレーションに関連する技術の進歩と調査活動の増加
  • 課題
    • 熟練した人材の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 MRIガイド下脳神経外科アブレーション市場：製品別

• アクセサリー
• MRI誘導集束超音波システム
• MRI誘導レーザーアブレーションシステム
• MRI誘導RFアブレーションシステム

第7章 MRIガイド下脳神経外科アブレーション市場：エンドユーザー別

• 外来手術センター
• クリニック
• 病院

第8章 南北アメリカのMRIガイド下脳神経外科アブレーション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のMRIガイド下脳神経外科アブレーション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのMRIガイド下脳神経外科アブレーション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Boston Scientific Corporation
• Cook Group Incorporated
• Monteris Medical Corporation
• Seattle Children's Hospital
• Siemens AG
• SternMed GmbH

LIST OF FIGURES

• FIGURE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET RESEARCH PROCESS
• FIGURE 2. MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MRI GUIDED NEUROSURGICAL ABLATION MARKET DYNAMICS
• TABLE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED FOCUSED ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED LASER ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED RF ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

The MRI Guided Neurosurgical Ablation Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.07 billion in 2024, and is projected to grow at a CAGR of 4.84%, to USD 5.42 billion by 2030.

The scope of MRI Guided Neurosurgical Ablation encompasses the use of MRI technology to guide minimally invasive surgical procedures intended to ablate or remove predefined volumes of brain tissue. This technology proves essential as it allows for precise targeting of pathologies, reducing potential damage to surrounding healthy tissue, thereby enhancing patient outcomes and recovery times. Its applications are broad, spanning neurological disorders such as epilepsy, brain tumors, and Parkinson's disease, while the end-use segments mainly involve hospitals, specialty clinics, and research institutions. Key growth factors include increasing prevalence of neurological disorders, rising demand for minimally invasive surgeries, and advancements in MRI technology that improve accuracy and safety. As healthcare infrastructure develops and aging populations expand, opportunities for market growth similarly enlarge. Integrating artificial intelligence for enhanced imaging interpretation and personalized treatment planning represents a potential area for innovation.

However, several limitations and challenges could inhibit market growth, such as high equipment costs and a demand for skilled professionals capable of operating complex technologies. Furthermore, regulatory and reimbursement challenges might impede swift market penetration, especially in developing regions with less robust healthcare systems. The highly competitive market landscape, with prominent players heavily investing in R&D, necessitates continuous innovation to maintain a competitive edge. Recommendations to seize emerging market opportunities include investments in AI-driven platform development, partnerships for broadening technology access, and expanding clinical trial programs to validate new therapeutic applications. Enhanced focus on educating both the medical community and patients about the benefits of MRI-guided procedures could drive adoption rates. Innovations should center on improving the procedural efficiency, cost-effectiveness, and therapeutic outcomes of MRI-guided ablations. A progressive approach to overcoming regulatory obstacles and addressing reimbursement issues is also crucial for sustainable growth. Given these dynamics, the market is expected to continue evolving rapidly, characterized by technological advancements and increasing adoption across more geographical regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
  • Surge in the adoption of minimally invasive neurosurgeries
  • Rise in the awareness of brain disorder diagnosis and treatment among patients
• Market Restraints
  • High cost associated with the MRI guided neurosurgical ablation
• Market Opportunities
  • Rapidly growing healthcare expenditures in emerging nations
  • Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
• Market Challenges
  • Lack of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the MRI Guided Neurosurgical Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Guided Neurosurgical Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Guided Neurosurgical Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Guided Neurosurgical Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Guided Neurosurgical Ablation Market

A detailed market share analysis in the MRI Guided Neurosurgical Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Guided Neurosurgical Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Guided Neurosurgical Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Guided Neurosurgical Ablation Market

A strategic analysis of the MRI Guided Neurosurgical Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Guided Neurosurgical Ablation Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cook Group Incorporated, Monteris Medical Corporation, Seattle Children's Hospital, Siemens AG, and SternMed GmbH.

Market Segmentation & Coverage

This research report categorizes the MRI Guided Neurosurgical Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems, and MRI Guided RF Ablation Systems.
• Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
    • 5.1.1.2. Surge in the adoption of minimally invasive neurosurgeries
    • 5.1.1.3. Rise in the awareness of brain disorder diagnosis and treatment among patients
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the MRI guided neurosurgical ablation
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapidly growing healthcare expenditures in emerging nations
    • 5.1.3.2. Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled manpower
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. MRI Guided Neurosurgical Ablation Market, by Product

• 6.1. Introduction
• 6.2. Accessories
• 6.3. MRI Guided Focused Ultrasound Systems
• 6.4. MRI Guided Laser Ablation Systems
• 6.5. MRI Guided RF Ablation Systems

7. MRI Guided Neurosurgical Ablation Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Clinics
• 7.4. Hospitals

8. Americas MRI Guided Neurosurgical Ablation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific MRI Guided Neurosurgical Ablation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa MRI Guided Neurosurgical Ablation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Boston Scientific Corporation
• 2. Cook Group Incorporated
• 3. Monteris Medical Corporation
• 4. Seattle Children's Hospital
• 5. Siemens AG
• 6. SternMed GmbH